Blog
RSS FeedPosted by Michael Wonder on 27 Apr 2018
Public Summary Documents – December 2017 PBAC meeting
27 April 2018 - The Public Summary Documents (first time rejections and deferrals) from the December 2017 PBAC meeting are now ...
Posted by Michael Wonder on 17 Apr 2018
Final minutes of December 2017 EMA/EUnetHTA meeting
16 April 2018 - The EMA has published the final minutes from the 15 December 2017 meeting. ...
Posted by Michael Wonder on 16 Apr 2018
CADTH 2018-2021 strategic plan
16 April 2018 - Dr. Brian O’Rourke, CADTH President and CEO, has released the CADTH 2018-2021 Strategic Plan. ...
Posted by Michael Wonder on 16 Apr 2018
ICER's final report on emicizumab shows new treatment improves health while lowering costs for certain people with haemophilia A
16 April 2018 - Report also highlights need for future pricing of haemophilia treatments that allows for "shared savings" between innovators ...
Posted by Michael Wonder on 12 Apr 2018
ICER releases draft evidence report on CGRP inhibitors for migraine prevention
11 April 2018 - Public comment period now open until 8 May; requests to make oral comment during public meeting also ...
Posted by Michael Wonder on 03 Apr 2018
Half yearly performance snapshot: July to December 2017
3 April 2018 - The TGA has maintained a high level of activity while also progressing regulatory reforms over the reporting ...
Posted by Michael Wonder on 27 Mar 2018
Gene therapy: international regulatory and health technology assessment activities and reimbursement status
28 March 2018 - There is widespread variation in the definition of gene therapy used by international regulatory bodies and a ...
Posted by Michael Wonder on 19 Mar 2018
Outcome statement - Feb 2018 Drug Utilisation Sub Committee meeting
16 March 2018 - The outcome statement from the February 2018 Drug Utilisation Sub Committee meeting is now available. ...
Posted by Michael Wonder on 18 Mar 2018
Public Summary Documents - November 2017 PBAC meeting
16 March 2018 - The Public Summary Documents (first time rejections and deferrals) from the November 2017 PBAC meeting are now ...
Posted by Michael Wonder on 16 Mar 2018
ICER releases draft evidence report on CFTR modulator therapies for cystic fibrosis
15 March 2018 - Public comment period now open until 12 April; requests to make oral comment during public meeting also ...
Posted by Michael Wonder on 02 Mar 2018
PBAC Drug Utilisation Sub Committee utilisation analysis public release documents
2 March 2018 - The utilisation analysis public release documents from the September 2017 DUSC meeting are now available. ...
Posted by Michael Wonder on 23 Feb 2018
Nusinersen stakeholder meeting outcome statement
23 February 2018 - The outcome statement for the nusinersen stakeholder meeting held on 18 January 2018 is now available. ...
Posted by Michael Wonder on 07 Feb 2018
Canadian generic drug prices higher than international levels in recent years
6 February 2018 - The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada. ...
Posted by Michael Wonder on 30 Jan 2018
Prescription medicines and biologicals: TGA annual summary 2017
30 January 2018 - This is TGA's fourth annual summary report on the registration of prescription medicines, which includes new generic ...
Posted by Michael Wonder on 30 Jan 2018
Post-market review of chronic obstructive pulmonary disease medicines – final report released
30 January 2018 - The final report and outcomes of the post-market review of chronic obstructive pulmonary disease medicines is now ...